NCT07302724

Brief Summary

The aim of this prospective randomized controlled study was to determine whether the timing of drain removal in relation to continuous passive motion (CPM) application influences postoperative residual hematoma formation following primary total knee arthroplasty (TKA). Our primary hypothesis was that removing the drain after initiating CPM would result in less residual hematoma, as CPM-induced intra-articular fluid and blood mobilization would be evacuated through the drain before its removal, thereby reducing postoperative fluid accumulation.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
104

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 10, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 24, 2025

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

December 24, 2025

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

December 10, 2025

Last Update Submit

December 23, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Residual Hematoma Formation

    Residual hematoma formation assessed by knee circumference measurements at the level of the superior pole of the patella. Circumference is measured on both the operated and contralateral knees. The difference from baseline and between-group differences are evaluated.

    Preoperative; Postoperative Day 2; Day 14; Day 28

Secondary Outcomes (6)

  • Wound Healing

    Postoperative Day 2; Day 14

  • Range of Motion (ROM)

    Preoperative; Postoperative Day 2; Day 14; Day 28

  • Pain Assessment

    Preoperative; Postoperative Day 14; Day 28

  • Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    Preoperative; Postoperative Day 28

  • Lysholm Knee Score

    Preoperative; Postoperative Day 28

  • +1 more secondary outcomes

Study Arms (2)

Drain Removal Before CPM

OTHER

The hemovac drain is removed approximately 24 hours after surgery, immediately before a standardized 1-hour CPM session performed at 0-90° flexion. All other perioperative and rehabilitation protocols are identical between groups.

Procedure: Drain Removal Before CPM

Drain Removal After CPM

OTHER

Patients undergo a standardized 1-hour CPM session at 0-90° flexion approximately 24 hours after surgery. The hemovac drain is removed immediately after completion of the CPM session. All other perioperative and rehabilitation protocols are identical between groups.

Procedure: Drain Removal After CPM

Interventions

Hemovac drain removal performed approximately 24 hours after primary TKA, immediately before a standardized 1-hour CPM session (0-90°). All other surgical, perioperative, and rehabilitation protocols are identical across study arms.

Drain Removal Before CPM

A standardized 1-hour CPM session at 0-90° is administered approximately 24 hours after primary TKA. The hemovac drain is removed immediately after completion of the CPM session. All other surgical, perioperative, and rehabilitation protocols are identical across study arms.

Drain Removal After CPM

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Undergoing primary unilateral total knee arthroplasty (TKA) for end-stage knee osteoarthritis
  • Able to provide written informed consent
  • Able to comply with scheduled postoperative follow-up assessments

You may not qualify if:

  • Revision total knee arthroplasty
  • Previous infection in the index knee
  • Inflammatory arthropathy
  • Neuromuscular disorders affecting lower extremity function
  • Inability to attend follow-up visits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Etlik City Hospital

Ankara, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two-arm prospective parallel-group comparison of drain removal timing.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Orthopedic Surgeon, Principal Investigator

Study Record Dates

First Submitted

December 10, 2025

First Posted

December 24, 2025

Study Start

June 15, 2025

Primary Completion

December 30, 2025

Study Completion

December 30, 2025

Last Updated

December 24, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations